Robot-assisted stomach cancer surgery after chemo or radiation
Part of Cancer, Digestive system clinical trials.
This trial tests whether using a robotic arm to remove stomach cancer is safe and effective for patients who have already received chemotherapy or radiation. If you have stage III stomach cancer and are healthy enough for surgery, this approach may offer a more precise operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You have been diagnosed with stomach cancer (or certain types of gastroesophageal junction cancer) and have already received chemotherapy or radiation before surgery.
- Your cancer is stage III, meaning it has spread to nearby lymph nodes but not to other organs, and a surgeon believes it can be completely removed.
- You are in good enough health to undergo surgery and can take care of yourself (ECOG score 0 or 1).
- Your heart, lungs, kidneys, and blood counts must be within safe ranges (no severe heart disease, uncontrolled bleeding, or active infections).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 3 trial compares robot-assisted surgery to standard laparoscopic surgery for treating stomach cancer that has grown through the stomach wall (cT4a) but not spread to distant organs. The goal is to see which approach may offer better outcomes.
This trial tests a minimally invasive surgery for stomach cancer that has spread to lymph nodes near the main blood vessels (para-aortic area). The surgery is done after a combination of chemotherapy and immunotherapy to shrink the tumor. It aims to see if this approach is safe and effective.
This trial tests the safety of using a robot to remove small stomach tumors (GISTs) that are in hard-to-reach places. It aims to see if robotic surgery is a good option for you.
This study tests combining an immunotherapy drug (PD-1 inhibitor) and a medication to boost your immune system (thymalfasin) with standard chemotherapy and radiation before surgery for stage III cancer where the stomach meets the esophagus. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial compares robotic and laparoscopic surgery for stomach cancer patients who have already received chemotherapy or targeted therapy. It aims to see which approach leads to better outcomes after neoadjuvant (pre-surgery) treatment.
This trial compares two types of robot-assisted operations to remove part of the stomach for gastric cancer. It aims to see which approach works better and is safer for achieving complete tumor removal.
Hear when a new Gastric Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.